Gates Foundation’s $40m Incentivizes Cancer Specialist Immunocore To Develop TB, HIV Drugs

 
• By Lucie Ellis-Taitt
  
map
Gates Foundation Invests In Immunocore For Development Of New Drugs To Benefit Global Population

More from Deals

More from Business